In a statement from the U.S. Food and Drug Administration, Commissioner Scott Gottlieb, M.D. discussed the agency’s continuing efforts to combat the spread of illicit opioids and to ensure the security of America’s drug supply chain. Included in their recent efforts, Commissioner Gottlieb noted that the agency has stepped up enforcement and interdiction work at International Mail Facilities and shut down websites illegally selling potentially dangerous, unapproved, and misbranded versions of opioid medications to U.S. citizens…

[...]

The board members of The Partnership for Safe Medicines praise the passage of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act” or the “SUPPORT for Patients and Communities Act, which includes the STOP Act. This legislation will have a positive impact on the fight to save lives and keep fentanyl out of the United States…

[...]

Although the U.S. Food and Drug Administration and Customs and Border Protection work hard to keep counterfeit medicines and fentanyl pills out of the U.S., they do still get in. Fake pharmaceuticals and personal care products were the seventh most frequently seized item in fiscal year 2017, and the increase of illicit fentanyl is only mirrored by the increase in the number of deaths caused by synthetic opioids…

[...]